Gabapentin and weight changes
Pro Research Analysisby 
Searched over 200M research papers
Gabapentin and Weight Gain: Clinical Evidence
Several studies have found that gabapentin use can lead to weight gain in a significant number of patients. In a long-term study of patients with seizure disorders treated with high-dose gabapentin for at least 12 months, over half experienced weight gain: 10 patients gained more than 10% of their baseline weight, and 15 gained 5–10%. Weight gain typically began between the second and third months of treatment and stabilized after 6–9 months, regardless of whether gabapentin was used alone or with other antiepileptic drugs . Another review of clinical records found that weight gain of more than 3 kg was observed in some patients on gabapentin, with an average gain of 6.9 kg, often noted within a few months of starting therapy. The effect appeared more common at higher doses .
Gabapentin Prodrugs and Comparative Weight Effects
Gabapentin enacarbil (GEn), a prodrug of gabapentin, was studied in adults with diabetic peripheral neuropathy. The incidence of weight gain was lower with GEn compared to pregabalin, another antiepileptic drug. Weight gain with GEn was dose-dependent, with 5–10% of patients experiencing at least a 7% increase in weight, compared to 15% with pregabalin and 3% with placebo. The average weight gain for GEn ranged from 1.2 to 1.9 kg over 12 weeks, which was less than that seen with pregabalin .
Long-Term Gabapentin Use and Weight Change
In patients with postherpetic neuralgia treated with a gastroretentive formulation of gabapentin for up to 24 weeks, the mean weight gain was less than 1 kg, and only 2.5% of patients reported weight increase as an adverse event. This suggests that while weight gain can occur, it may be modest in some populations and with certain formulations .
Gabapentin and Weight in Special Populations
In infants treated with gabapentin for various indications, there was a statistically significant improvement in weight-for-age Z scores over two weeks, suggesting a positive effect on weight gain in this group. Gabapentin was well tolerated, with few adverse events . In animal studies, gabapentin did not cause significant changes in body weight over a 30-day period, though other organ effects were noted .
Gabapentin and Weight Loss Prevention
Interestingly, in patients undergoing head and neck cancer therapy, prophylactic gabapentin was associated with less weight loss compared to controls, indicating a potential benefit in preventing weight loss in this specific context .
Weight Change After Discontinuation
Data from studies of other antiepileptic drugs suggest that discontinuing gabapentin may be associated with weight loss, though the number of patients in these analyses was small .
Conclusion
Gabapentin is associated with weight gain in a notable proportion of patients, especially at higher doses and with long-term use 13. The degree of weight gain varies by formulation, dose, and patient population, with some studies showing only modest increases 24. In certain clinical scenarios, such as cancer therapy or in infants, gabapentin may help prevent weight loss or support weight gain 56. Overall, while weight gain is a recognized side effect of gabapentin, its magnitude and clinical significance depend on individual patient factors and treatment context.
Sources and full results
Most relevant research papers on this topic